The new Medicare payment model aims to take down wasteful spending, but Congress and analysts point out potential problems.
Richard Payerchin
Advertisement
Richard Payerchin is editor of Medical Economics.
Articles by Richard Payerchin
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
CVS Health’s Breakup: A Turning Point for Pharma Supply Chains or a Redistribution of Market Power?
2
Pharma Pulse: Lilly and Hims & Hers Team Up, Swisslog Expands Tenutō Cold Storage
3
Why the Next Wave of Drug Launches Will Be Won on Market Access
4
Executive Conversations: Why Specialty Drug Networks Should Start Small
5